AI Summary & Key Takeaways
AI InsightIn this report, we present a young female patient who had a 32-year-old withoutorganic disease who developed urinary retention requiring urinary catheterization after the use of duloxetine.
📌 3 Key Takeaways
Abstract
Side effects are one of the most important obstacles to the use of psychotropic drugs. Although duloxetine, commonly used in clinicalpractice, is known to be an effective and reliable antidepressant, it is known to cause some side effects. Although it has been reportedin the literature that urinary side effects such as urination difficulties and frequent urination may be encountered, especially in men,it is very rare in women. Urinary retention is defined that is sudden onset of inability to void or presence of important amount ofpostmicturitional residual urine. It has been reported that drug-induced urinary retention may be associated with psychotropic drugssuch as olanzapine, sertraline, aripiprazole and duloxetine in the literature. The cases associated with duloxetine were generally seenin combination form and with organic pathologies. As far as we know, the young female patient who has no organic pathology has nourinary retention associated with the use of duloxetine. In this report, we present a young female patient who had a 32-year-old withoutorganic disease who developed urinary retention requiring urinary catheterization after the use of duloxetine.